The treatment of polymyositis, dermatomyositis and inclusion body myositis

Eugeniusz Kucharz; Małgorzata Widuchowska; Magdalena Kopeć-Mędrek; Anna Kotulska

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2010
vol. 48

Send email

Copy url:

abstract:

Review paper

The treatment of polymyositis, dermatomyositis and inclusion body myositis

Eugeniusz J. Kucharz

,

Małgorzata Widuchowska

,

Magdalena Kopeć-Mędrek

,

Anna Kotulska

Reumatologia 2010; 48, 3: 188–193

Online publish date: 2010/07/02

View full text Get citation

Idiopathic inflammatory myopathy is a group of diseases of unknown etiology and probably autoimmune pathogenesis. Treatment of the diseases is divided into following stages: initial phase, intermediate phase, and long-lasting therapy. Glicocorticoids and other immunosuppressive drugs (commonly azathioprine and methotrexate) are applied for management. It is important to evaluate activity of the disease, effectiveness of the treatment and occurrence of adverse reactions. Inclusion body myositis is resistant to glicocorticoid therapy.

keywords:

polymyositis, dermatomyositis, glicocorticoids, steroid myopathy

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

The treatment of polymyositis, dermatomyositis and inclusion body myositis

Eugeniusz J. Kucharz , Małgorzata Widuchowska , Magdalena Kopeć-Mędrek , Anna Kotulska

polymyositis, dermatomyositis, glicocorticoids, steroid myopathy

Eugeniusz J. Kucharz

,

Małgorzata Widuchowska

,

Magdalena Kopeć-Mędrek

,

Anna Kotulska